At the early stage of the outbreak of COVID-2019, Biotecan developed Novel Coronavirus 2019-nCoV Nucleic Acid Detection Kit (Real Time PCR) and SARS-CoV-2 IgM/IgG Rapid Test by Colloidal Gold Method. On March 10, 2020, the two kits were granted CE certification, which means they can be commercially sold in the EU market. As both kits putting formally into production, they will be hugely helpful for fast spread infection globally.

The two kits granted by CE certification were as follows:

- Novel Coronavirus 2019-nCoV Nucleic Acid Detection Kit (Real Time PCR)

- SARS-CoV-2 IgM/IgG Rapid Test by Colloidal Gold Method

The Novel Coronavirus 2019-nCoV Nucleic Acid Detection Kit (Real Time PCR) was granted CE certification

The SARS-CoV-2 IgM/IgG Rapid Test by Colloidal Gold Method was granted CE certification

The sudden outbreak of COVID-19 which started in early 2020 is a war without any smoke. Under the premise of controlling the epidemic and taking good care of our employee, Biotecan has made every effort to ensure all ongoing projects are on schedule. During these challenging times, in accordance with our mission which is to provide high-quality medical services to the public with advanced technology, Biotecan continues to provide professional services for our global customers and make due contributions to the world.